Sharps Compliance Corp
SMED
SMED was delisted on the 22nd of August, 2022.
0 hedge funds and large institutions have $0 invested in Sharps Compliance Corp in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 67 closing their positions.
100% less funds holding
Funds holding: 67 → 0 (-67)
100% less capital invested
Capital invested by funds: $25.1M → $0 (-$25.1M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 67
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$2.9M |
| 2 |
RA
Royce & Associates
New York
|
-$2.49M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.14M |
| 4 |
Renaissance Technologies
New York
|
-$1.55M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.38M |
SMED Hedge Fund Activity: Q3 2022 in Review
0 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Sharps Compliance Corp (SMED) for Q3 2022, worth a combined $0 — down 100% from $25.1M a quarter earlier.
Sellers outnumbered buyers: 67 funds closed out of SMED and 0 opened new positions — a net loss of 67 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Wasatch Advisors, exiting entirely with an estimated $2.9M sold.
- 0 institutional investors held Sharps Compliance Corp (SMED) as of Q3 2022, down from 67 in Q2 2022.
- Funds reported $0 of Sharps Compliance Corp stock for Q3 2022, down 100% quarter-over-quarter.
- 0 funds opened new Sharps Compliance Corp positions in Q3 2022 and 67 closed out, a net change of -67 holders.
- The largest Sharps Compliance Corp seller in Q3 2022 was Wasatch Advisors, an estimated $2.9M sold.
Based on aggregated 13F filings for Q3 2022.